Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Nkarta Inc (NKTX)

Nkarta Inc (NKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights GlobeNewswire - Wed May 14, 3:01PM CDT

NKTX : 1.7000 (-2.30%)
Nkarta to Participate in an April Investor Conference GlobeNewswire - Tue Apr 1, 7:01AM CDT

NKTX : 1.7000 (-2.30%)
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights GlobeNewswire - Wed Mar 26, 3:01PM CDT

NKTX : 1.7000 (-2.30%)
Nkarta to Participate in March Investor Conferences GlobeNewswire - Tue Feb 25, 7:01AM CST

NKTX : 1.7000 (-2.30%)
Nkarta, Inc. Opens Enrollment for Ntrust-2 Trial Evaluating NKX019 in Multiple Autoimmune Diseases Quiver Quantitative, Inc. - Thu Dec 5, 2024

Nkarta opens Ntrust-2 trial for NKX019 in systemic sclerosis, myositis, and vasculitis; myasthenia gravis trial also initiated.Quiver AI SummaryNkarta, Inc. has announced the opening of patient enrollment...

NKTX : 1.7000 (-2.30%)
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2 GlobeNewswire - Thu Dec 5, 2024

NKTX : 1.7000 (-2.30%)
Nkarta to Participate in an Upcoming Investor Conference GlobeNewswire - Tue Nov 26, 2024

NKTX : 1.7000 (-2.30%)
Nkarta to Participate in an Upcoming Investor Conference GlobeNewswire - Tue Nov 12, 2024

NKTX : 1.7000 (-2.30%)
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights GlobeNewswire - Thu Nov 7, 2024

NKTX : 1.7000 (-2.30%)
Why Nkarta Stock Is Soaring Today Motley Fool - Wed Aug 14, 2024

One analyst is now more bullish about this clinical-stage biotech stock.

NKTX : 1.7000 (-2.30%)
RJF : 153.81 (-0.05%)

Barchart Exclusives

Should You Buy This Dividend-Paying Gold Stock in 2025? Barchart - Mon May 19, 6:30PM CDT
With gold prices soaring above $3,200 an ounce, Kinross Gold is poised for further growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot